Cargando…
Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
Osteoporosis is a common skeletal disorder, often leading to fragility fracture. Combination therapy with raloxifene, a selective estrogen receptor modulator, and cholecalciferol (vitamin D(3)) has been proposed to improve the overall efficacy and increase compliance of raloxifene therapy for postme...
Autores principales: | Lee, Hae Won, Kang, Woo Youl, Jung, Wookjae, Gwon, Mi‐Ri, Cho, Kyunghee, Lee, Backhwan, Seong, Sook Jin, Yoon, Young‐Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305550/ https://www.ncbi.nlm.nih.gov/pubmed/34984851 http://dx.doi.org/10.1002/cpdd.1062 |
Ejemplares similares
-
A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers
por: Lee, Hae Won, et al.
Publicado: (2022) -
Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2020) -
Pharmacokinetics and Pharmacodynamics of YYD601, a Dual Delayed-Release Formulation of Esomeprazole, Following Single and Multiple Doses in Healthy Adult Volunteers Under Fasting and Fed Conditions
por: Lee, Hae Won, et al.
Publicado: (2022) -
Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects
por: Lee, Hae Won, et al.
Publicado: (2020) -
A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
por: Kang, Woo Youl, et al.
Publicado: (2020)